SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-18-041503
Filing Date
2018-08-02
Accepted
2018-08-02 06:01:49
Documents
3
Group Members
JEREMY C. GREEN

Document Format Files

Seq Description Document Type Size
1 SC 13D tv499944_sc13d.htm SC 13D 97628
2 EXHIBIT 99.1 tv499944_ex99-1.htm EX-99.1 6166
3 EXHIBIT 99.5 tv499944_ex99-5.htm EX-99.5 21994
  Complete submission text file 0001144204-18-041503.txt   127400
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Subject) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87649 | Film No.: 18986486
SIC: 2836 Biological Products, (No Diagnostic Substances)